REQUEST A DEMO
Total
USD $0.00
Search more companies

Ambrosia Bioscience SRL (Romania)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Ambrosia Bioscience SRL Profile Updated: August 22, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Ambrosia Bioscience SRL is an enterprise in Romania, with the main office in CLUJ-NAPOCA. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on December 04, 2003. 3 (2022) employees currently work for Ambrosia Bioscience SRL. The company’s latest financial report indicates a net sales revenue increase of 14.01% in 2022. There was a total growth of 23.6% in Ambrosia Bioscience SRL’s total assets over the same period. The enterprise’s net profit margin decreased by 0.81% in 2022.

Headquarters
Strada Remetea Nr. 10
CLUJ-NAPOCA; Cluj; Postal Code: 400344

Contact Details: Purchase the Ambrosia Bioscience SRL report to view the information.

Website: http://www.ambrosiabio.com

Basic Information
Total Employees:
Purchase the Ambrosia Bioscience SRL report to view the information.
Outstanding Shares:
Purchase the Ambrosia Bioscience SRL report to view the information.
Registered Capital:
Purchase the Ambrosia Bioscience SRL report to view the information.
Incorporation Date:
December 04, 2003
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Ambrosia Bioscience SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
14.01%
Total operating revenue
13.66%
Operating profit (EBIT)
8.51%
EBITDA
6.87%
Net Profit (Loss) for the Period
11.09%
Total assets
23.6%
Total equity
-15.52%
Operating Profit Margin (ROS)
-1.59%
Net Profit Margin
-0.81%
Return on Equity (ROE)
23.9%
Quick Ratio
-0.11%
Cash Ratio
-0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?